Highlights
A collection of news and information related to Hepatitis C published by this site and its partners.
Displaying items 1-12 of 103
» View wsbt.com items only
1
2
3
4
5
6
7
8
9
•
Next >
-
DEALTALK-Novartis' Vasella exit opens door to Roche stake sale
Reuters* Novartis' one-third stake in Roche built up under Vasella * Vasella exit, retirement of Roche chairman could thaw relations * Roche seen as most likely buyer for the stake * Could make offer in second half of this year - analyst By Caroline...Tags: Parties and Movements, Elections, Zurich (Swiss Confederation), Politics, Genentech Inc.
-
Experimental Gilead drug effective in early-stage leukemia trial
Reuters(Reuters) - An experimental drug from Gilead Sciences Inc shrank tumors in half of leukemia patients whose cancer had returned, according to an early-stage trial that represents a new foray into oncology by the world's biggest seller of HIV medications....Tags: Leukemia, Chemotherapy, Ice Hockey, Symptoms, Pharmaceuticals
-
Yale Researchers Urge More Street Work When Studying People With Both HIV, Hepatitis C
The Hartford CourantResearchers need to work harder to screen high-risk populations for people who are infected with both HIV and hepatitis C, say the authors of a new Yale University study on the incidence of co-infection in the New Haven area. The study, published Tuesday...Tags: Health and Safety at School, Hepatitis, Yale School of Medicine, New Haven (New Haven, Connecticut), U.S. Centers for Disease Control and Prevention
-
Abbvie says Chief Scientific Officer John Leonard to retire
ReutersMay 10 (Reuters) - AbbVie Inc's chief scientific officer will be retiring in the next few months and will be involved in the process of naming a successor, the pharmaceutical company said in a regulatory filing on Friday. Chief Scientific Officer John M....Tags: Science, Pharmaceuticals, Chemical Industry, Science and Technology, Rheumatoid Arthritis
-
Muchos estadounidenses no se realizan el examen adecuado para la hepatitis C: CDC
ReutersPor Julie Steenhuysen NUEVA YORK (Reuters) - Funcionarios de salud pública de Estados Unidos informaron que sólo la mitad de la población que alguna vez estuvo infectada con el virus de la hepatitis C se realizó la prueba de detección adecuada...Tags: Diseases and Illnesses, Disease Prevention, Viral Diseases and Infections, U.S. Centers for Disease Control and Prevention
-
Many with hepatitis C don't get needed follow-up tests, CDC says
Half of all patients who have tested positive for hepatitis C have not had follow-up testing to see if they are still infected, according to the Centers for Disease Control and Prevention. That means many people are living with the disease and not...
Tags: Diseases and Illnesses, Hepatitis, Disease Prevention, Cirrhosis, Medical Procedures and Tests
-
Many in U.S. don't get proper testing for hepatitis C- CDC
ReutersBy Julie Steenhuysen NEW YORK, May 8 (Reuters) - Only half of people in the United States who have ever been infected with hepatitis C get proper testing for the liver-destroying disease, according to U.S. health officials. Proper testing is a two-...Tags: Hepatitis, Disease Prevention, U.S. Centers for Disease Control and Prevention, Liver Cancer, Diseases and Illnesses
-
REUTERS SUMMIT-Biotech firms evolve from targets to acquirers
Reuters(For other news from Reuters Health Summit, click on http://www.reuters.com/summit/Health13) * Skyrocketing valuations quash talks * With financing available, many biotechs go it alone * Bankers expect steady flow of $1 bln to $5 bln pharma deals By...Tags: Companies and Corporations, Pharmaceuticals, Biotechnology, Economy, Business and Finance, Biotechnology Industry
-
FDA fast tracks AbbVie hepatitis C drug
Tribune reporterAbbVie said Monday that its new hepatitis C drug regimen has been given a breakthrough therapy designation by the Food and Drug Administration, putting it on the fast track for potential approval in the United States. A breakthrough therapy...Tags: Food and Drug Administration, Diseases and Illnesses, Hepatitis, Vaccines, Trials
-
Additional question from Dr. Christopher Prince interview
Is Michigan’s law effective? The law has become more specific giving more definitions and clarifying explanations of its intent. The State has a list of approved diagnoses, which is to be expanded yearly, and conditions approved for the use of...Tags: Multiple Sclerosis, Diseases and Illnesses, Glaucoma, Medical Marijuana Therapy, HIV
-
International consortium releases hepatitis C data
Two antiviral drugs used to treat hepatitis C appear to work as well in the real world as they did during clinical trials, an international research consortium has observed. The consortium also released data that may help inform how doctors and patients...Tags: Health and Safety at School, Food and Drug Administration, Colleges and Universities, Education, Financial Aid
-
Vertex posts quarterly loss as hepatitis C drug sales fall
ReutersApril 30 (Reuters) - Vertex Pharmaceuticals Inc on Tuesday reported a fourth successive quarterly loss as sales of its hepatitis C drug, Incivek, continued to plunge, but the biotechnology company raised its forecast for sales of a cystic fibrosis drug...Tags: Chemical Industry, Biotechnology, Science and Technology, Vertex Pharmaceuticals Incorporated, Biotechnology Industry
May 16, 2013
|Story| Reuters
May 15, 2013
|Story| Reuters
May 14, 2013
|Story| Hartford Courant
May 10, 2013
|Story| Reuters
May 9, 2013
|Story| Reuters
May 8, 2013
|Story| Los Angeles Times
May 8, 2013
|Story| Reuters
May 7, 2013
|Story| Reuters
May 6, 2013
|Story| Chicago Tribune
May 4, 2013
|Story| South Bend Tribune
May 2, 2013
|Story| South Florida Sun-Sentinel
Apr 30, 2013
|Story| Reuters
Original site for Hepatitis C topic gallery.